| Financial Year |
March 31 2023 |
| Monetary Funds |
1,039,252,731.53 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
87,781,641.11 |
| Advances to Suppliers |
52,682,112.18 |
| Other Receivables |
21,255,356.35 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
414,886,020.61 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
118,031,580.17 |
| Total Current Assets |
1,733,889,441.95 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
710,271,298.77 |
| Under-construction Projects |
194,422,965.64 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
159,951,354.63 |
| R&D expenses |
-- |
| Goodwill |
39,778,196.68 |
| Long-Term Deferred and Prepaid Expenses |
35,427,642.38 |
| Deferred Income Tax Assets |
34,171,016.75 |
| Other Non-Current Assets |
14,342,512.36 |
| Sub-Total of Non-Current Assets |
1,217,932,206.94 |
| Total Assets |
2,951,821,648.89 |
| Short-Term Loans |
100,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
68,518,693.13 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
12,536,860.59 |
| Taxes Payable |
15,571,263.36 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
135,923,400.69 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,604,627.13 |
| Other Current Liabilities |
1,283,543.71 |
| Sub-Total of Current Liabilities |
352,327,090.78 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
184,026,983.73 |
| Total Liabilities |
536,354,074.51 |
| Paid-In Capital(Or Share Stock) |
512,304,224.00 |
| Capital Surplus |
687,543,217.40 |
| Surplus Reserve |
154,478,921.26 |
| LESS:Treasury Stock |
85,486,583.67 |
| Undistributed Profits |
1,112,270,968.65 |
| Minority Stockholder's Interest |
34,356,826.74 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,381,110,747.64 |
| Owner's Equity（Stockholder's Equity） |
2,415,467,574.38 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,951,821,648.89 |
